Latest news
Stay up to date on the latest activities and publications from hera
Archive
- 2023
- 2024
- 2025
- Aarti Patel
- Accountability
- Afghanistan
- Africa
- Alejandra Martinez
- Algeria
- Alice Behrendt
- Alice Peschiutta
- Angola
- Anne Buve
- Argentina
- Asia Pacific
- Assessment
- Bangladesh
- Basic Health Services / Primary health care
- Behaviour Change Communication
- Belize
- Benin (Dahomey)
- Botswana
- Cabo Verde
- Calvin Tonga
- Cambodia
- Caribbean
- Central Asia
- Chad
- Child Protection
- Children
- Chile
- Cholera
- Climate change
- Colombia
- Communicable diseases (CD)
- Community Engagement
- Community Health Workers
- Comoros
- Costing studies
- Country Capacity
- Covid-19
- Crisis Management
- Côte d'Ivoire
- DRC
- Demand side financing
- Development
- Development Cooperation
- Dia Timmermans
- Dijbouti
- Drug Pricing
Sustaining health system progress in fragile settings: Lessons from South Kivu
Improving health outcomes in fragile and conflict-affected settings requires sustained commitment, resilient systems, and alignment between programmes and broader contextual realities.
A recent assessment led by hera examined the impact of the fifth round of the Programme d’Appui au Système de Santé du Sud Kivu (PASS V) on the health system and population outcomes in South Kivu in the Democratic Republic of Congo. The programme was supported by the Swiss Agency for Development and Cooperation (DDC) through its office in Bukavu. The evaluation aimed to assess programme performance, capture lessons learned and inform future investments—including the ongoing Programme Santé Maternelle et Infantile (PSaMI).
Bridging the Gap in Health Care Services in DRC with the ASSR Programme
Operating in four provinces of DRC – Nord Ubangi, Kasai, Kasai Central, and Maniema – the ASSR programme targets an estimated population of 9 million. The anticipated maximum value of the ASSR programme over its 18-month duration is £35 million.
SADC Feasibility Study on Regional Manufacturing of Medicines and Health Commodities
Assess the feasibility of the local production of essential medicines especially those related to the three communicable diseases, namely HIV and AIDS, TB and Malaria as well as the production of health commodities for the three diseases.